Meeting
2019 ASCO Annual Meeting
Impact of body composition on outcomes from anti-programmed death-1 (PD-1) treatment.
Authors
Arissa Young
Vanderbilt University Medical Center, Nashville, TN
Arissa Young , Henry T. Quach , Elizabeth J. Davis , Javid Moslehi , Grant R. Williams , Douglas Buckner Johnson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9516)
DOI
10.1200/JCO.2019.37.15_suppl.9516
Abstract #
9516
Poster Bd #
87
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Body composition measurements and overall survival in patients with resectable pancreatic adenocarcinoma receiving neoadjuvant chemotherapy: Analysis from SWOG S1505.
First Author: Davendra Sohal
First Author: Jessica Hopkins
Poster
2020 ASCO Virtual Scientific Program
Impact of body measurements (BM) on overall survival (OS) and quality of life (QoL) in real-world patients (pts) with metastatic esophageal cancer.
First Author: Joelle Soriano
Poster
2016 ASCO Annual Meeting
Changes in body composition and prognostic importance of sarcopenia in patients receiving CTRT for oropharyngeal cancer.
First Author: Shrujal S. Baxi